Avaleht › Endomeetriumivähk › Oregon
Endomeetriumivähk kliinilised uuringud osariigis Oregon
27 uuringut haiguse Endomeetriumivähk jaoks otsivad osalejaid osariigis Oregon.
Linnad osariigis Oregon
Ametlik uuringutekst (inglise keeles)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- ja veel 1
VärbamineFaas 2
Kõik vanused · Kõik sood · Uuendatud 2. okt 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
VärbamineFaas 1/2
Vanused 12 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT04585750Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Naised · Uuendatud 2. okt 2026 · NCT07198074A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Site 02, Portland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07814248Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
VärbamineFaas 2
Vanused 18 ja vanemad · Naised · Uuendatud 28. sept 2026 · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Portland
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT05867251Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Portland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT06218914Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Providence Portland Medical Centre, Portland
- Providence Saint Vincent Medical Center, Portland
VärbamineFaas 2
Vanused 18 ja vanemad · Naised · Uuendatud 24. sept 2026 · NCT05640999A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Oncology Associates of Oregon, P.C. ( Site 8005), Eugene
VärbamineFaas 3
Vanused 18 ja vanemad · Naised · Uuendatud 17. sept 2026 · NCT06952504Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Providence Portland Medical Center, Portland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06293898Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
- NW Cancer Specs. P.C., Happy Valley
- USOR - NW Cancer Specs P.C., Portland
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Naised · Uuendatud 9. sept 2026 · NCT07166094A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
- Providence Cancer Institute of Oregon, Portland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT06515613DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Eugene
VärbamineFaas 3
Vanused 18 ja vanemad · Naised · Uuendatud 3. sept 2026 · NCT06989112Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Portland
VärbamineFaas 1/2
Vanused 18–130 · Kõik sood · Uuendatud 21. aug 2026 · NCT05797168FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT05919264A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. aug 2026 · NCT06242470Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Oncology Associates of Oregon, P.C., Eugene
- Compass Oncology - Rose Quarter, Portland
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. aug 2026 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Oregon Health & Science University, Portland
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. juuli 2026 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Eugene
- Research Site, Portland
VärbamineFaas 3
Vanused 18 ja vanemad · Naised · Uuendatud 29. juuli 2026 · NCT07044336Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #121, Portland
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. juuli 2026 · NCT06974110Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 517, Eugene
VärbamineFaas 2
Vanused 18 ja vanemad · Naised · Uuendatud 16. juuli 2026 · NCT06906341First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Providence Cancer Institute Franz Clinic, Portland
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 7. juuli 2026 · NCT05768139cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40 ja vanemad · Kõik sood · Uuendatud 20. jaan 2026 · NCT05366881Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Oncology Associates of Oregon, P.C., Eugene
- Northwest Cancer Specialists, P.C., Portland
VärbamineFaas 2
Vanused 18 ja vanemad · Naised · Uuendatud 24. dets 2025 · NCT06463028SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 28. okt 2025 · NCT03452774A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Oregon Health & Science University, Portland
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. veebr 2025 · NCT05669430Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Oncology Associates of Oregon, Eugene
- Northwest Cancer Specialists, Portland
VärbamineFaas 2/3
Vanused 18 ja vanemad · Naised · Uuendatud 2. mai 2024 · NCT05797831Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.